Holen Sie sich die Stockscreener-App
7.24
2.69%
-0.20
Handel nachbörslich:
7.11
-0.13
-1.80%
Schlusskurs vom Vortag:
$7.44
Offen:
$7.49
24-Stunden-Volumen:
1.18M
Relative Volume:
0.78
Marktkapitalisierung:
$741.61M
Einnahmen:
$187.64M
Nettoeinkommen (Verlust:
$-95.00M
KGV:
-7.6211
EPS:
-0.95
Netto-Cashflow:
$-69.02M
1W Leistung:
-8.93%
1M Leistung:
-0.28%
6M Leistung:
+7.10%
1J Leistung:
-46.49%
1-Tages-Spanne:
$7.23
$7.51
1-Wochen-Bereich:
$7.135
$8.01
52-Wochen-Spanne:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Vergleichen Sie DAWN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.24 | 762.09M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
Signal strength of Day One Biopharmaceuticals Inc. stock in tech scannersJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
How to recover losses in Day One Biopharmaceuticals Inc. stockJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-10-10 04:42:27 - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - MarketBeat
Is Day One Biopharmaceuticals Inc. stock oversold or undervaluedJuly 2025 News Drivers & Risk Managed Investment Strategies - newser.com
Published on: 2025-10-09 05:35:06 - newser.com
Day One Biopharmaceuticals Hits Day Low of $7.27 Amid Price Pressure - Markets Mojo
Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last? - Nasdaq
How to read the order book for Day One Biopharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Smart tools for monitoring Day One Biopharmaceuticals Inc.’s price actionStock Surge & AI Forecasted Entry/Exit Points - newser.com
Can volume confirm reversal in Day One Biopharmaceuticals Inc.Trade Volume Summary & Growth Focused Stock Reports - newser.com
Day One Biopharmaceuticals Experiences Evaluation Revision Amidst Market Challenges and Mixed Performance Indicators - Markets Mojo
Live market analysis of Day One Biopharmaceuticals Inc.2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
What makes Day One Biopharmaceuticals Inc. stock attractive to growth fundsWeekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
What analysts say about Day One Biopharmaceuticals Inc stockSupport Zone Identification & High Profit Market Ideas - earlytimes.in
What drives Day One Biopharmaceuticals Inc stock priceMarket Sentiment Shifts & Maximize ROI With Proven Growth Stocks - earlytimes.in
H.C. Wainwright Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛
H.C. Wainwright reiterates Buy rating on Day One Biopharmaceuticals stock By Investing.com - Investing.com Canada
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts - MarketBeat
Institutional scanner results for Day One Biopharmaceuticals Inc.July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
Rhumbline Advisers Boosts Stock Position in Day One Biopharmaceuticals, Inc. $DAWN - Defense World
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Day One Biopharmaceuticals Inc-Aktie (DAWN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dubow Adam | Gen Counsel & Secretary |
Aug 18 '25 |
Sale |
6.77 |
4,365 |
29,538 |
54,858 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
6.77 |
16,058 |
108,666 |
161,365 |
| Merendino Lauren | Chief Commercial Officer |
Aug 18 '25 |
Sale |
6.77 |
3,766 |
25,485 |
41,931 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):